Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD

Añadir a la lista de favoritos

10,33

-0,50

(-4,62%)

Al cierre: 04:00PM EDT

10,58

+0,25

(+2,42%)

Después del cierre:

07:45PM EDT

Accionistas principales

Lista de personas con información privilegiada

Transacciones de accionistas miembros de la empresa

Divisa en USD

Compras de personas con información privilegiada de los 6 últimos meses	Acciones	Trans
Compras	113.500	10
Ventas	3.730.296	4
Cuotas netas adquiridas (vendidas)	-3.616.796	14
Acciones de persona con información privilegiada totales	5,31M	N/A
% de acciones netas adquiridas (vendidas)	-40,50%	N/A

Compras institucionales netas del trimestre anterior al último trimestre	Acciones
Cuotas netas adquiridas (vendidas)	N/A
% de cambio en la posesión de acciones institucionales	N/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiada	Transacción	Tipo	Valor	Fecha	Acciones
HENDERSON MOLLY Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	31 may 2024	7.500
NABULSI AZMI M.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	31 may 2024	7.500
KARBE FRANK L Director	Stock Award(Grant) at price 10.16 per share.	Directo	254.112	29 may 2024	25.000
FIELDS-KUNZ HEIDI Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 may 2024	10.500
KARBE FRANK L Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 may 2024	10.500
TOPPER JAMES N Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 may 2024	10.500
SOCKS DAVID A Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 may 2024	10.500
STENHOUSE MARK Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 may 2024	10.500
COLA MICHAEL F Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 may 2024	10.500
PARIKH ASIT Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	23 may 2024	10.500
HENDERSON MOLLY Chief Financial Officer	Sale at price 11.10 per share.	Directo	38.128	08 abr 2024	3.435
CURRAN TERRIE Chief Executive Officer	Sale at price 9.11 per share.	Directo	153.513	22 mar 2024	16.851
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 6.71 per share.	Directo	24.833.329	24 ene 2024	3.703.703
HENDERSON MOLLY Chairman of the Board	Sale at price 7.75 per share.	Directo	48.900	19 ene 2024	6.307
HENDERSON MOLLY Chief Financial Officer	Sale at price 7.24 per share.	Directo	15.403	20 nov 2023	2.127
PARIKH ASIT Director	Purchase at price 7.76 - 8.04 per share.	Directo	58.580	08 nov 2023	7.500
HENDERSON MOLLY Chairman of the Board	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 nov 2023	22.500
HENDERSON MOLLY Chairman of the Board	Sale at price 7.80 - 8.95 per share.	Directo	110.871	01 nov 2023	12.492
CURRAN TERRIE Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 nov 2023	37.500
NABULSI AZMI M.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 nov 2023	32.500
HENDERSON MOLLY Chief Financial Officer	Stock Award(Grant) at price 14.06 per share.	Directo	351.500	14 jul 2023	25.000
HENDERSON MOLLY Chairman of the Board	Stock Award(Grant) at price 0.00 per share.	Directo	0	14 jul 2023	25.000
CURRAN TERRIE Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	14 jul 2023	200.000
NABULSI AZMI M.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	14 jul 2023	110.000
HENDERSON MOLLY Chief Financial Officer	Sale at price 11.41 per share.	Directo	22.368	02 jun 2023	1.960
PARIKH ASIT Director	Stock Award(Grant) at price 11.66 per share.	Directo	174.900	02 jun 2023	15.000
FIELDS-KUNZ HEIDI Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	25 may 2023	9.000
KARBE FRANK L Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	25 may 2023	9.000
TOPPER JAMES N Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Directo	0	25 may 2023	9.000
SOCKS DAVID A Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	25 may 2023	9.000
STENHOUSE MARK Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	25 may 2023	9.000
COLA MICHAEL F Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	25 may 2023	9.000
PARIKH ASIT Director	Stock Award(Grant) at price 0.00 per share.	Directo	0	25 may 2023	9.000
HENDERSON MOLLY Chief Financial Officer	Sale at price 12.87 per share.	Directo	27.165	22 may 2023	2.110
NABULSI AZMI M.D. Chief Operating Officer	Purchase at price 8.26 per share.	Directo	82.600	11 abr 2023	10.000
PARIKH ASIT Director	Purchase at price 7.55 per share.	Directo	7.550	10 abr 2023	1.000
HENDERSON MOLLY Chief Financial Officer	Sale at price 7.27 per share.	Directo	25.002	06 abr 2023	3.439
CURRAN TERRIE Chief Executive Officer	Purchase at price 7.82 per share.	Directo	101.025	06 abr 2023	12.919
HENDERSON MOLLY Chief Financial Officer	Sale at price 8.53 per share.	Directo	17.335	01 mar 2023	2.032
CURRAN TERRIE Chief Executive Officer	Sale at price 8.54 per share.	Directo	12.265	01 mar 2023	1.436
PARIKH ASIT Director	Purchase at price 7.73 per share.	Directo	38.660	13 feb 2023	5.000
CURRAN TERRIE Chief Executive Officer	Sale at price 8.20 per share.	Directo	47.729	20 ene 2023	5.821
HENDERSON MOLLY Chairman of the Board	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 ene 2023	33.000
CURRAN TERRIE Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 ene 2023	97.500
NABULSI AZMI M.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 ene 2023	45.000
PARIKH ASIT Director	Purchase at price 7.00 per share.	Directo	35.000	12 ene 2023	5.000
HENDERSON MOLLY Chief Financial Officer	Sale at price 9.60 per share.	Directo	20.726	21 nov 2022	2.159
CURRAN TERRIE Chief Executive Officer	Sale at price 9.60 per share.	Directo	14.650	21 nov 2022	1.526
HENDERSON MOLLY Chairman of the Board	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 sept 2022	7.500
CURRAN TERRIE Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 sept 2022	7.500
NABULSI AZMI M.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	01 sept 2022	7.500
HENDERSON MOLLY Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 may 2022	12.000
CURRAN TERRIE Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 may 2022	12.000
NABULSI AZMI M.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 may 2022	12.000
NABULSI AZMI M.D. Chief Operating Officer	Purchase at price 8.16 per share.	Indirecto	163.288	16 may 2022	20.000
HENDERSON MOLLY Chief Financial Officer	Purchase at price 7.99 per share.	Directo	47.940	13 may 2022	6.000
CURRAN TERRIE Chief Executive Officer	Purchase at price 7.41 per share.	Directo	151.835	13 may 2022	20.500
PARIKH ASIT Director	Purchase at price 8.00 per share.	Directo	100.000	12 may 2022	12.500
HENDERSON MOLLY Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	05 abr 2022	20.000
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 12.23 per share.	Directo	220	14 mar 2022	18
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security		Directo		14 mar 2022	7.359.304
GUZZO ANTHONY J Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 ene 2022	6.000
CURRAN TERRIE Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 ene 2022	41.250
NABULSI AZMI M.D. Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Directo	0	19 ene 2022	19.500
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 20.85 - 23.83 per share.	Directo	20.850.024	04 nov 2021	1.000.001
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security		Directo		04 nov 2021	228.696
SOCKS DAVID A Director	Sale at price 32.05 - 32.66 per share.	Indirecto	586.395	08 oct 2021	18.000
SOCKS DAVID A Director	Sale at price 32.06 - 33.31 per share.	Indirecto	587.351	22 sept 2021	18.000
SOCKS DAVID A Director	Sale at price 30.47 - 31.49 per share.	Indirecto	562.538	16 ago 2021	18.000
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.05 per share.	Directo	91.445	07 jul 2021	2.609
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.01 - 35.16 per share.	Directo	292.727	02 jul 2021	8.326
SOCKS DAVID A Director	Sale at price 34.00 - 35.09 per share.	Indirecto	1.361.941	29 jun 2021	40.000
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.08 - 36.07 per share.	Directo	869.427	28 jun 2021	24.501
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.00 - 35.14 per share.	Directo	388.199	24 jun 2021	11.048
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.00 - 35.31 per share.	Directo	331.671	22 jun 2021	9.394
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.08 - 35.13 per share.	Directo	305.571	18 jun 2021	8.703
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.06 per share.	Directo	99.080	14 jun 2021	2.826
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.14 - 35.28 per share.	Directo	115.883	10 jun 2021	3.293
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.00 - 35.05 per share.	Directo	82.853	08 jun 2021	2.364
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.18 per share.	Directo	151.274	02 jun 2021	4.300
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.37 - 37.55 per share.	Directo	723.434	01 jun 2021	20.116
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 36.45 - 37.55 per share.	Directo	766.700	27 may 2021	20.811
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.58 - 36.59 per share.	Directo	773.889	25 may 2021	21.541
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.10 - 35.74 per share.	Directo	665.439	21 may 2021	18.746
SOCKS DAVID A Director	Sale at price 31.96 - 35.27 per share.	Indirecto	1.305.506	20 may 2021	40.000
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.00 per share.	Directo	3.500	14 may 2021	100
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.33 - 36.06 per share.	Directo	420.892	13 may 2021	11.876
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.03 per share.	Directo	35.415	07 may 2021	1.011
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.01 - 35.14 per share.	Directo	250.803	06 may 2021	7.138
TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security	Sale at price 35.50 - 39.06 per share.	Directo	1.257.849	04 may 2021	33.992
NABULSI AZMI M.D. Chief Operating Officer	Sale at price 36.15 - 38.59 per share.	Indirecto	548.656	04 may 2021	14.500
SOCKS DAVID A Director	Sale at price 34.96 - 38.03 per share.	Indirecto	1.462.089	06 abr 2021	40.000
NABULSI AZMI M.D. Chief Operating Officer	Sale at price 35.66 - 38.14 per share.	Indirecto	531.102	05 abr 2021	14.500
CURRAN TERRIE Chief Executive Officer	Sale at price 43.24 - 44.08 per share.	Directo	498.751	22 mar 2021	11.513
CURRAN TERRIE Chief Executive Officer	Conversion of Exercise of derivative security at price 6.95 per share.	Directo	80.015	22 mar 2021	11.513
SOCKS DAVID A Director	Sale at price 46.67 - 49.93 per share.	Indirecto	2.617.090	12 mar 2021	55.000
RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security	Sale at price 43.75 per share.	Indirecto	31.062.500	11 mar 2021	710.000
NABULSI AZMI M.D. Chief Operating Officer	Sale at price 44.59 - 46.73 per share.	Indirecto	665.290	02 mar 2021	14.500
SOCKS DAVID A Director	Sale at price 42.50 - 47.61 per share.	Indirecto	3.254.612	23 feb 2021	70.000
NABULSI AZMI M.D. Chief Operating Officer	Sale at price 38.09 - 41.16 per share.	Indirecto	578.441	02 feb 2021	14.500
SOCKS DAVID A Director	Sale at price 34.92 - 36.18 per share.	Indirecto	1.428.038	12 ene 2021	40.000
SOCKS DAVID A Director	Sale at price 40.49 - 48.99 per share.	Indirecto	3.458.896	17 dic 2020	79.658
NABULSI AZMI M.D. Chief Operating Officer	Sale at price 43.99 - 45.57 per share.	Indirecto	648.688	02 dic 2020	14.500
SOCKS DAVID A Director	Stock Gift at price 0.00 per share.	Indirecto	0	01 dic 2020	27.000
SOCKS DAVID A Director	Sale at price 38.17 - 44.00 per share.	Indirecto	1.253.198	11 nov 2020	30.342
NABULSI AZMI M.D. Chief Operating Officer	Sale at price 36.83 per share.	Indirecto	534.026	02 nov 2020	14.500
NABULSI AZMI M.D. Chief Operating Officer	Stock Gift at price 0.00 per share.	Directo	0	25 jun 2020	867.200
RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 24.86 per share.	Indirecto	2.923.642	01 abr 2020	117.600
RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 24.55 - 24.60 per share.	Indirecto	1.489.264	31 mar 2020	60.600
NABULSI AZMI M.D. Chief Operating Officer	Sale at price 33.02 - 34.57 per share.	Indirecto	487.275	03 ene 2020	14.500
FRAZIER LIFE SCIENCES IX , L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 19.00 per share.	Indirecto	19.999.989	29 oct 2019	1.052.631
FRAZIER LIFE SCIENCES IX , L.P. Beneficial Owner of more than 10% of a Class of Security		Indirecto		29 oct 2019	1.353.640
EDWARDS JONATHAN S Director	Purchase at price 19.00 per share.	Indirecto	19.999.989	29 oct 2019	1.052.631
EDWARDS JONATHAN S Director	Conversion of Exercise of derivative security at price 15.20 per share.	Indirecto	15.431.496	29 oct 2019	1.015.230
COLA MICHAEL F Director	Purchase at price 19.00 per share.	Directo	186.162	29 oct 2019	9.798

IBEX 3511.166,10+47,20(+0,42%)

Euro Stoxx 504.972,15+36,18(+0,73%)

Dólar/Euro1,0697-0,0018(-0,17%)

Petróleo Brent85,27+0,26(+0,31%)

Oro2.325,90-4,90(-0,21%)

Bitcoin EUR57.677,17+964,60(+1,70%)

Phathom Pharmaceuticals, Inc. (PHAT)

Transacciones de accionistas miembros de la empresa

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

IBEX 35
11.166,10
+47,20(+0,42%)

Euro Stoxx 50
4.972,15
+36,18(+0,73%)

Dólar/Euro
1,0697
-0,0018(-0,17%)

Petróleo Brent
85,27
+0,26(+0,31%)

Oro
2.325,90
-4,90(-0,21%)

Bitcoin EUR
57.677,17
+964,60(+1,70%)